Abstract
This activity will update pharmacists and other healthcare professionals on current treatments for pseudobulbar affect (PBA). Points of discussion will focus on the off-label therapies traditionally used to treat PBA, the FDA-approved combination drug product with PBA as an indication, and managed care aspects of treating PBA.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Antidepressive Agents, Tricyclic / therapeutic use*
-
Drug Approval
-
Drug Therapy / methods*
-
Drugs, Investigational / therapeutic use*
-
Female
-
Humans
-
Male
-
Medication Therapy Management
-
Patient Safety*
-
Pseudobulbar Palsy / diagnosis
-
Pseudobulbar Palsy / drug therapy*
-
Risk Assessment
-
Selective Serotonin Reuptake Inhibitors / therapeutic use*
-
Treatment Outcome
-
United States
-
United States Food and Drug Administration
Substances
-
Antidepressive Agents, Tricyclic
-
Drugs, Investigational
-
Serotonin Uptake Inhibitors